Cargando…
Neovascularization of angle following trabeculectomy augmented with mitomycin-C
The purpose of this study was to report a case of neovascularization of angle (NVA) following trabeculectomy with mitomycin-c (MMC) in a patient with primary open-angle glaucoma. This case report describes a 68-year-old woman who developed NVA and hyphema 2 weeks following an uneventful trabeculecto...
Autores principales: | Shalaby, Wesam Shamseldin, Razeghinejad, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095308/ https://www.ncbi.nlm.nih.gov/pubmed/34084037 http://dx.doi.org/10.4103/ojo.OJO_71_2020 |
Ejemplares similares
-
Evaluation of topical bevacizumab as an adjunct to mitomycin C augmented trabeculectomy
por: Zarei, Reza, et al.
Publicado: (2016) -
Effect of Mitomycin-C Augmented Trabeculectomy on Corneal Endothelial Cells
por: Zarei, Reza, et al.
Publicado: (2015) -
Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma
por: Maheshwari, Devendra, et al.
Publicado: (2019) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey, Hatem M, et al.
Publicado: (2011) -
Comments on: Mid-term outcome of mitomycin C-augmented trabeculectomy in open-angle glaucoma versus angle-closure glaucoma
por: Pathak-Ray, Vanita
Publicado: (2020)